Executive Secretary

VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

neuroepoplus ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

Tuesday 14
November 2023

IDENTIFICATION OF A CRITICAL QUALITY ATTRIBUTE FOR THE ACTIVE PHARMACEUTICAL INGREDIENT OF NEUROEPOplus
Jani Laffitte García

actividad neuroprotectora atributo crítico de calidad. critical quality attribute. isoform profile neuroepoplus neuroprotective activity perfil de isoformas

DEVELOPMENT OF AN IN VITRO BIOASSAY FOR HUMAN ERYTHROPOIETIN WITH A LOW CONTENT IN SIALIC ACID (NEUROEPOplus) BASED ON PROLIFERATIVE STIMULATION OF AN ERYTHROID CELL LINE
Wilden Diaz González

apoptosis epor inhibición inhibition neuroepoplus potencia potency proliferación proliferation tf1

Instituto Finlay de Vaunas

EAA Heriberto Duquesne

Gold

Álamo Empresa Cárnica

Silver

BIOCUBAFARMA

Centro de Análisis del Ciclo de Vida (CADIS)